THE EFFECT OF EICOSAPENTAENOIC ACID (EPA) ON BIOMARKERS OF GROWTH AND VASCULARITY IN HUMAN COLORECTAL CANCER LIVER METASTASES

Mise à jour : Il y a 5 ans
Référence : EUCTR2009-015903-22

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The study aims to show the first evidence of anti-cancer properties of EPA in human colorectal cancer liver metastases (CRCLM). In particular we want to see if treatment with EPA daily is associated with a lower ‘proliferation index’ (the amount of tumour cell growth) in CRCLM compared with placebo.


Critère d'inclusion

  • Colorectal cancer liver metastases

Liens